Washington, D.C. – U.S. Senators Charles Schumer and Kirsten
Gillibrand today announced more than $2.2 million to upgrade and improve
resources at Buffalo medical research institutions, including SUNY at Buffalo
and Roswell Park Cancer Institute Corporation. The federal dollars will help
move forward on critical research and treatment to help improve the lives of
all New Yorkers, and are part of the American
Recovery and Reinvestment Act, which Senators Schumer and Gillibrand helped
pass earlier this year.
“Investing in these institutions makes sense in both the short run and the long
run,” said Schumer. “Immediately it will create jobs and advance
Buffalo’s position at the cutting edge of the medical research, while in the
long run it will allow our parents and grandparents to live longer, healthier
lives.”
“It is critical that we invest in the life-saving research
at our world class facilities in Buffalo,” said Senator Gillibrand. “Federal
funding for this cutting edge research will help with medical diagnosis and
treatment while promoting economic growth in Western New York. During these
tough economic times, I will continue to work with Senator Schumer to ensure
that New York receives its fair share of federal dollars.”
SUNY at Buffalo will receive $2,000,000 to make broad expansions into
multidimensional translational cardiovascular research. Roswell Park Cancer
Institute Corporation will receive $216,662 for research into lung, head, neck
and colon cancer, as well as treatments for better disease management.
Senators Schumer and Gillibrand are strong supporters of
President Obama’s economic plan. The investment will help create or save more
than 200,000 jobs in New York, while laying the foundation of future economic
growth with critical investments in health care technology, education,
infrastructure and renewable energy.